Improving people’s health by targeting their microbiome

SURI BioTech is a biotechnology company, developing health promoting bacterial strains with targeted mechanisms of action for the alleviation of bloating and intestinal discomfort.  SURI BioTech proprietary strains reduce the production of hydrogen gas by intestinal microorganisms – with potential applications in multiple functional gastrointestinal disorders (e.g. infant colic, lactose intolerance, bloating). BactoKind, our first application, is a food supplement for the alleviation of infant colic.

Supported by